BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

NCT07196111 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

B Acute Lymphoblastic Leukemia/Lymphoma

Interventions

BIOLOGICAL: BAFFR CAR-T

Sponsor

Guangzhou Bio-gene Technology Co., Ltd